Allergan Launches Be the Difference Philanthropic Program

February 4, 2020

Allergan has announced its Be the Difference philanthropic program supporting children and their families who may benefit from treatment with Botox (onabotulinumtoxinA) for pediatric upper limb spasticity. Botox is approved to treat increased muscle stiffness in children 2 to 17 years of age with upper limb spasticity. Botox Cosmetic is approved for three aesthetic indications, and Botox is approved for 11 therapeutic indications in the U.S. During the month of February, every Botox Cosmetic treatment recorded in Brilliant Distinctions, Allergan’s loyalty reward program, will help Allergan contribute up to a total of $500,000 to foundations that help children across the country.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Sends Peptide ‘Interim Access Policy’ to White House for Review
    • New ACOG Menopause Guidelines Expand Hormone Therapy and Symptom Treatment Recommendations
    • Galderma to Acquire ZO Skin Health for $1.5 Billion
    • AscendPoint Agency Acquires Medical Marketing Whiz
    • PracticeQ Becomes Platinum Vendor Affiliate with the American Med Spa Association